Refine
Year of publication
Document Type
- Article (76)
Has Fulltext
- yes (76)
Is part of the Bibliography
- no (76)
Keywords
- data science (19)
- machine-learning (7)
- Data science (6)
- pain (6)
- Machine-learning (5)
- artificial intelligence (5)
- digital medicine (5)
- machine learning (5)
- patients (5)
- Pain (3)
- Biomedical informatics (2)
- Data processing (2)
- Functional clustering (2)
- Olfactory system (2)
- Probability density (2)
- Probability distribution (2)
- human genomics (2)
- knowledge discovery (2)
- neuropathic pain (2)
- olfaction (2)
- Addiction (1)
- Analgesia (1)
- Anosmia (1)
- Autoimmune encephalomyelitis (1)
- B cells (1)
- Bioinformatics (1)
- Breast cancer survivers (1)
- Cannabis (1)
- Chronification (1)
- Clincial pharmacology (1)
- Clinical genetics (1)
- Clustering (1)
- Cold pain (1)
- Computer hardware (1)
- Computer software (1)
- DNA methylation (1)
- Data preprocessing (1)
- Data reduction (1)
- Data structure detection (1)
- Diagnostic markers (1)
- Genetics research (1)
- Heat pain (1)
- Human (1)
- Human experimental pain models (1)
- Human olfaction (1)
- Lpar2 (1)
- Lymphoma (1)
- Lysophosphatidic acids (1)
- Machine learning (1)
- Machine learning algorithms (1)
- Mathematical functions (1)
- Molecular diagnosis (1)
- Multiple sclerosis (1)
- Mutations (1)
- NGS sequencing (1)
- Neuroinflammation (1)
- Neuronal networks (1)
- Normal distribution (1)
- Nutrition (1)
- OPRM1 methylation (1)
- Olfactory diagnostics (1)
- Opioid system (1)
- Patients (1)
- Pharm-fMRI (1)
- Pharmacometrics (1)
- Post surgery pain (1)
- Predictive medicine (1)
- Pressure pain (1)
- Principal component analysis (1)
- Quality of life (1)
- Quantitative sensory testing (1)
- R programming language (1)
- R software (1)
- Sex differences (1)
- Software tools (1)
- Spinal cord (1)
- Statistical data (1)
- Subgroup identification (1)
- T-cell homing (1)
- analgesia (1)
- analgesics (1)
- back pain (1)
- benchmark standards (1)
- bioinformatics (1)
- biomarker (1)
- breast cancer (1)
- clinical research (1)
- clustering (1)
- cold induced pain (1)
- computational functional genomics (1)
- computational knowledge-discovery (1)
- computational techniques (1)
- data modeling (1)
- data projection (1)
- data quality check (1)
- dementia (1)
- diabetes mellitus (1)
- emergent self-organizing maps (1)
- endocannabinoids (1)
- experimental human pain models (1)
- experimental pain models (1)
- extracellular matrix (1)
- functional genomics (1)
- functional imaging (1)
- heterogeneity of plasticity effects (1)
- high dimensional complex data (1)
- high-dimensional data sets (1)
- human brain (1)
- human experimental pain (1)
- human olfaction (1)
- human pain models (1)
- human pharmacology (1)
- human research (1)
- human subjects (1)
- immunological research (1)
- intervertebral disc (1)
- lipidomic analysis (1)
- lipids (1)
- molecular mechanisms (1)
- multiple sclerosis (1)
- next generation sequencing (1)
- next generation sequencing (NGS) (1)
- next-generation sequencing (1)
- olfactory testing (1)
- pain genetics (1)
- paired continuous theta burst stimulation (1)
- patient–doctor relationship (1)
- performance tests (1)
- persisting pain (1)
- pharmacoepigenetics (1)
- pharmacogenomics (1)
- pharmacological data science (1)
- pharmacological plasticity (1)
- polymorphism (1)
- postoperative pain (1)
- proteomics (1)
- psychological questionnaires (1)
- quantitative sensory testing (1)
- sensory neuropathy (1)
- subject selection (1)
- supervised machine-learning (1)
- t-distributed stochastic neighbor embedding (1)
- transcranial magnetic stimulation (1)
- trigeminal pain (1)
- μ-opioid receptor regulation (1)
- flow cytometry (1)
Institute
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
(2017)
Bioactive lipids contribute to the pathophysiology of multiple sclerosis. Here, we show that lysophosphatidic acids (LPAs) are dysregulated in multiple sclerosis (MS) and are functionally relevant in this disease. LPAs and autotaxin, the major enzyme producing extracellular LPAs, were analyzed in serum and cerebrospinal fluid in a cross-sectional population of MS patients and were compared with respective data from mice in the experimental autoimmune encephalomyelitis (EAE) model, spontaneous EAE in TCR1640 mice, and EAE in Lpar2 -/- mice. Serum LPAs were reduced in MS and EAE whereas spinal cord LPAs in TCR1640 mice increased during the ‘symptom-free’ intervals, i.e. on resolution of inflammation during recovery hence possibly pointing to positive effects of brain LPAs during remyelination as suggested in previous studies. Peripheral LPAs mildly re-raised during relapses but further dropped in refractory relapses. The peripheral loss led to a redistribution of immune cells from the spleen to the spinal cord, suggesting defects of lymphocyte homing. In support, LPAR2 positive T-cells were reduced in EAE and the disease was intensified in Lpar2 deficient mice. Further, treatment with an LPAR2 agonist reduced clinical signs of relapsing-remitting EAE suggesting that the LPAR2 agonist partially compensated the endogenous loss of LPAs and implicating LPA signaling as a novel treatment approach.
Based on increasing evidence suggesting that MS pathology involves alterations in bioactive lipid metabolism, the present analysis was aimed at generating a complex serum lipid-biomarker. Using unsupervised machine-learning, implemented as emergent self-organizing maps of neuronal networks, swarm intelligence and Minimum Curvilinear Embedding, a cluster structure was found in the input data space comprising serum concentrations of d = 43 different lipid-markers of various classes. The structure coincided largely with the clinical diagnosis, indicating that the data provide a basis for the creation of a biomarker (classifier). This was subsequently assessed using supervised machine-learning, implemented as random forests and computed ABC analysis-based feature selection. Bayesian statistics-based biomarker creation was used to map the diagnostic classes of either MS patients (n = 102) or healthy subjects (n = 301). Eight lipid-markers passed the feature selection and comprised GluCerC16, LPA20:4, HETE15S, LacCerC24:1, C16Sphinganine, biopterin and the endocannabinoids PEA and OEA. A complex classifier or biomarker was developed that predicted MS at a sensitivity, specificity and accuracy of approximately 95% in training and test data sets, respectively. The present successful application of serum lipid marker concentrations to MS data is encouraging for further efforts to establish an MS biomarker based on serum lipidomics.
Background: Cannabis proofed to be effective in pain relief, but one major side effect is its influence on memory in humans. Therefore, the role of memory on central processing of nociceptive information was investigated in healthy volunteers.
Methods: In a placebo-controlled cross-over study including 22 healthy subjects, the effect of 20 mg oral Δ9-tetrahydrocannabinol (THC) on memory involving nociceptive sensations was studied, using a delayed stimulus discrimination task (DSDT). To control for nociceptive specificity, a similar DSDT-based study was performed in a subgroup of thirteen subjects, using visual stimuli.
Results: For each nociceptive stimulus pair, the second stimulus was associated with stronger and more extended brain activations than the first stimulus. These differences disappeared after THC administration. The THC effects were mainly located in two clusters comprising the insula and inferior frontal cortex in the right hemisphere, and the caudate nucleus and putamen bilaterally. These cerebral effects were accompanied in the DSDT by a significant reduction of correct ratings from 41.61% to 37.05% after THC administration (rm-ANOVA interaction "drug" by "measurement": F (1,21) = 4.685, p = 0.042). Rating performance was also reduced for the visual DSDT (69.87% to 54.35%; rm-ANOVA interaction of "drug" by "measurement": F (1,12) = 13.478, p = 0.003) and reflected in a reduction of stimulus-related brain deactivations in the bilateral angular gyrus.
Conclusions: Results suggest that part of the effect of THC on pain may be related to memory effects. THC reduced the performance in DSDT of nociceptive and visual stimuli, which was accompanied by significant effects on brain activations. However, a pain specificity of these effects cannot be deduced from the data presented.
An important measure in pain research is the intensity of nociceptive stimuli and their cortical representation. However, there is evidence of different cerebral representations of nociceptive stimuli, including the fact that cortical areas recruited during processing of intranasal nociceptive chemical stimuli included those outside the traditional trigeminal areas. Therefore, the aim of this study was to investigate the major cerebral representations of stimulus intensity associated with intranasal chemical trigeminal stimulation. Trigeminal stimulation was achieved with carbon dioxide presented to the nasal mucosa. Using a single‐blinded, randomized crossover design, 24 subjects received nociceptive stimuli with two different stimulation paradigms, depending on the just noticeable differences in the stimulus strengths applied. Stimulus‐related brain activations were recorded using functional magnetic resonance imaging with event‐related design. Brain activations increased significantly with increasing stimulus intensity, with the largest cluster at the right Rolandic operculum and a global maximum in a smaller cluster at the left lower frontal orbital lobe. Region of interest analyses additionally supported an activation pattern correlated with the stimulus intensity at the piriform cortex as an area of special interest with the trigeminal input. The results support the piriform cortex, in addition to the secondary somatosensory cortex, as a major area of interest for stimulus strength‐related brain activation in pain models using trigeminal stimuli. This makes both areas a primary objective to be observed in human experimental pain settings where trigeminal input is used to study effects of analgesics.
Background: The categorization of individuals as normosmic, hyposmic, or anosmic from test results of odor threshold, discrimination, and identification may provide a limited view of the sense of smell. The purpose of this study was to expand the clinical diagnostic repertoire by including additional tests. Methods: A random cohort of n = 135 individuals (83 women and 52 men, aged 21 to 94 years) was tested for odor threshold, discrimination, and identification, plus a distance test, in which the odor of peanut butter is perceived, a sorting task of odor dilutions for phenylethyl alcohol and eugenol, a discrimination test for odorant enantiomers, a lateralization test with eucalyptol, a threshold assessment after 10 min of exposure to phenylethyl alcohol, and a questionnaire on the importance of olfaction. Unsupervised methods were used to detect structure in the olfaction-related data, followed by supervised feature selection methods from statistics and machine learning to identify relevant variables. Results: The structure in the olfaction-related data divided the cohort into two distinct clusters with n = 80 and 55 subjects. Odor threshold, discrimination, and identification did not play a relevant role for cluster assignment, which, on the other hand, depended on performance in the two odor dilution sorting tasks, from which cluster assignment was possible with a median 100-fold cross-validated balanced accuracy of 77–88%. Conclusions: The addition of an odor sorting task with the two proposed odor dilutions to the odor test battery expands the phenotype of olfaction and fits seamlessly into the sensory focus of standard test batteries.
Internalin B–mediated activation of the membrane-bound receptor tyrosine kinase MET is accompanied by a change in receptor mobility. Conversely, it should be possible to infer from receptor mobility whether a cell has been treated with internalin B. Here, we propose a method based on hidden Markov modeling and explainable artificial intelligence that machine-learns the key differences in MET mobility between internalin B–treated and –untreated cells from single-particle tracking data. Our method assigns receptor mobility to three diffusion modes (immobile, slow, and fast). It discriminates between internalin B–treated and –untreated cells with a balanced accuracy of >99% and identifies three parameters that are most affected by internalin B treatment: a decrease in the mobility of slow molecules (1) and a depopulation of the fast mode (2) caused by an increased transition of fast molecules to the slow mode (3). Our approach is based entirely on free software and is readily applicable to the analysis of other membrane receptors.